about
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle p...
Read More
64.64
2.13
(3.41%)
2.5M
XNAS Volume
XNAS 12 Jan, 2026 4:30 PM (EST)
Board Meeting
The latest board meeting for Cytokinetics Inc took place on 12 Jan 2026, for the purpose of 44th Annual J.P. Morgan Healthcare Conference
See details
Not Eligible
Expensive Valuation
Technically Bullish
Cytokinetics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..